Preliminary studies revealed that the CLEC12A TriKE proficiently directs NK‐cell‐mediated cytotoxicity towards CLEC12A‐expressing AML cells, in an antigen‐dependent fashion. Here, CLEC12A is linked to acute myeloid leukemia.